Where I see patients (3)
Selected research
-
Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period.
JBMR plus
-
Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose Level.
The Journal of clinical endocrinology and metabolism
-
Long-term Burosumab Administration Is Safe and Effective in Adults With X-linked Hypophosphatemia.
The Journal of clinical endocrinology and metabolism
Contact me
Feeling at home
From bedside bingo to therapy dogs, we're here to help kids smile and feel more like themselves.
Visit Child Life services![](/-/media/project/ucsf/ucsf-bch/images/by-your-side-moment/bear/bys_footer_bear-neutral-2x.jpg?rev=81c20662c2cc4692822f4b8583f01035&hash=16F72F4D46749F5692334687A5843450)